118 related articles for article (PubMed ID: 4197736)
1. [Studies on the tuberculostatic activity on new benzaledhyde and thiophene-aldehyde thiosemicarbazones in vitro and in vivo].
Wagner WH; Winkelmann E
Arzneimittelforschung; 1972 Oct; 22(10):1713-6. PubMed ID: 4197736
[No Abstract] [Full Text] [Related]
2. [New thiosemicarbazones, active against pox viruses].
Winkelmann E; Rolly H
Arzneimittelforschung; 1972 Oct; 22(10):1704-13. PubMed ID: 4677061
[No Abstract] [Full Text] [Related]
3. Discovery of new antitubercular oxazolyl thiosemicarbazones.
Sriram D; Yogeeswari P; Thirumurugan R; Pavana RK
J Med Chem; 2006 Jun; 49(12):3448-50. PubMed ID: 16759086
[TBL] [Abstract][Full Text] [Related]
4. [Experimental and clinical study of a new thiosemicarbazone derivative-Soliutizon].
Utkin VV; Makarevich NM; Krylova NP; Fedorova IE; Solov'eva FA
Probl Tuberk; 1966; 44(7):45-50. PubMed ID: 4969290
[No Abstract] [Full Text] [Related]
5. Synthesis and antituberculosis activity of 5-methyl/trifluoromethoxy-1H-indole-2,3-dione 3-thiosemicarbazone derivatives.
Güzel O; Karali N; Salman A
Bioorg Med Chem; 2008 Oct; 16(19):8976-87. PubMed ID: 18804379
[TBL] [Abstract][Full Text] [Related]
6. [A new combined tuberculostatic remedy].
KOSSMANN F
Tuberkulosearzt; 1954 Aug; 8(8):479-81. PubMed ID: 13205728
[No Abstract] [Full Text] [Related]
7. Studies on pyrazine derivatives. XXXII. Synthesis and tuberculostatic activity of acetylpyrazine thiosemicarbazone derivatives.
Milczarska B; Foks H; Trapkowski Z; Milzyńska-Kołaczek A; Janowiec M; Zwolska Z; Andrzejczyk Z
Acta Pol Pharm; 1998; 55(4):289-95. PubMed ID: 9821394
[TBL] [Abstract][Full Text] [Related]
8. [Comparative data from an experimental-clinical study of new antituberculosis drugs].
Utkin VV
Antibiotiki; 1972 Sep; 17(9):851-6. PubMed ID: 4631726
[No Abstract] [Full Text] [Related]
9. [Tuberculostatic activity of two derivatives of benzaldehyde thiosemicarbazone].
RIST N; PORTELLA A
Boll Ist Sieroter Milan; 1952; 31(7-8):318-20. PubMed ID: 12987475
[No Abstract] [Full Text] [Related]
10. Studies on pyrazine derivatives. XXXIII. Synthesis and tuberculostatic activity of 1-[1-(2-pyrazinyl)-ethyl]-4-N-substituted thiosemicarbazide derivatives.
Milczarska B; Foks H; Sokołowska J; Janowiec M; Zwolska Z; Andrzejczyk Z
Acta Pol Pharm; 1999; 56(2):121-6. PubMed ID: 10635356
[TBL] [Abstract][Full Text] [Related]
11. Cyclooctadiene Ru(II) complexes of thiophene-2-carboxaldehyde-derived thiosemicarbazones: synthesis, characterization and antiamoebic activity.
Singh S; Athar F; Maurya MR; Azam A
Eur J Med Chem; 2006 May; 41(5):592-8. PubMed ID: 16545496
[TBL] [Abstract][Full Text] [Related]
12. [In vitro and in vivo tuberculostatic effects of gentamicin on Mycobacterium tuberculosis].
Sula L; Sulová J; Spurná M; Jedlicková Z; Bárová V
Cas Lek Cesk; 1970 Apr; 109(17):369-75. PubMed ID: 4986208
[No Abstract] [Full Text] [Related]
13. [Some questions on chemotherapy with ethionamide].
Utkin VV; Fedorova IE
Probl Tuberk; 1967; 45(7):49-55. PubMed ID: 4974096
[No Abstract] [Full Text] [Related]
14. 5-Nitrofuran-2-yl derivatives: synthesis and inhibitory activities against growing and dormant mycobacterium species.
Sriram D; Yogeeswari P; Dhakla P; Senthilkumar P; Banerjee D; Manjashetty TH
Bioorg Med Chem Lett; 2009 Feb; 19(4):1152-4. PubMed ID: 19131245
[TBL] [Abstract][Full Text] [Related]
15. Antimycobacterial activity of 2-acetylpyridine thiosemicarbazones in relation to their antileprosy activity.
Morrison NE; Collins FM
Int J Lepr Other Mycobact Dis; 1981 Jun; 49(2):180-6. PubMed ID: 7196888
[TBL] [Abstract][Full Text] [Related]
16. [Incidence of drug sensitivity decrease in tuberculosis bacteria in untreated tuberculoses using autopsy material].
Schuh D; Justus J; Wichmann G
Z Erkr Atmungsorgane; 1974 Mar; 140(1):91-8. PubMed ID: 4212675
[No Abstract] [Full Text] [Related]
17. [Criteria of mycobacterium resistance to thioacetazone and cross resistance to ethionamide].
Afanas'eva IuP; Mkrtchian SV
Probl Tuberk; 1969; 47(3):66-9. PubMed ID: 4982181
[No Abstract] [Full Text] [Related]
18. Synthesis and evaluation of nitrofuranylamides as novel antituberculosis agents.
Tangallapally RP; Yendapally R; Lee RE; Hevener K; Jones VC; Lenaerts AJ; McNeil MR; Wang Y; Franzblau S; Lee RE
J Med Chem; 2004 Oct; 47(21):5276-83. PubMed ID: 15456272
[TBL] [Abstract][Full Text] [Related]
19. [Clinical results of a peroral combination therapy in infantile tuberculosis].
RUZICZKA O
Wien Klin Wochenschr; 1954 Jul; 66(26):465-8. PubMed ID: 13205948
[No Abstract] [Full Text] [Related]
20. [Antibacterial effect of Soliutizon].
Pershin GN; Makeeva OO
Probl Tuberk; 1966; 44(7):63-7. PubMed ID: 4969291
[No Abstract] [Full Text] [Related]
[Next] [New Search]
